Loncom Pharma provides Perampanel APIs, which are crucial for the formulation of cutting-edge antiepileptic drugs. Perampanel works by selectively antagonizing AMPA receptors, which play a significant role in the propagation of seizures. With a focus on quality and regulatory compliance, these APIs help in formulating treatments that improve the quality of life for patients with epilepsy by effectively reducing seizure frequency.
